Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Learn ways to align every expenditure with your financial goals. Prioritize essential spending, reduce waste, and monitor goal progress.
23,330 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
A wave of budget-conscious shoppers is steering growth at discount grocers, reshaping grocery traffic and profits. An...
When a growth stock slips, investors scramble to understand if the fall is temporary or the start of a bigger trend. ...
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
GO Mortgage unveils a TPO channel built on a new wholesale platform, led by Rob Saunders, aiming to streamline origin...
Institutional demand is intensifying as XRP hovers near key support. Whales running long while, alongside rising open...
Tesla sits around $445 as Q1 margin gains meet AI roadmap momentum, prompting fresh Buy, Sell or Hold questions for i...
Ford shows a weakness in its truck lineup, and GM may push harder to capture share in the high-margin segment. This a...
Ranger Investment Management recently boosted its WaterBridge stake, signaling potential confidence in WaterBridge In...
Harvard's endowment has sold its entire Ethereum stake after a short-lived bet, marking another reset in its crypto s...
Microsoft sits at a pivotal price near $420 as quarterly results underscore AI momentum and capex intensity. This rep...
Two billionaire investors, two very different plays on Alphabet. One backs a measured, Buffett-like approach; the oth...